✦ LIBER ✦

Resistance to activated protein C due to the factor V Leiden mutation: a risk factor for chemotherapy-associated thrombosis

✍ Scribed by Oberhoff, C.; Göge, S.; Hoffmann, O.; Winkler, U.H.; Schindler, A.E.

Book ID: 121993372
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 274 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(99)81956-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tamoxifen-associated venous thrombosis a

Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V leiden

✍ Ilene C. Weitz; Valerie K. Israel; Howard A. Liebman 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 2 views

## BACKGROUND. Thromboembolic events are well recognized complications of can-

Mesenteric arterial thrombosis due to ac

Mesenteric arterial thrombosis due to activated protein C resistance (factor V Leiden)

✍ Francisco Gomez; Antonio Rodriguez; Jose Rivas; Jose M. Baez; Sotero Romero; Dan 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 498 KB

Activated protein C resistance and the f

Activated protein C resistance and the factor V Leiden mutation in children with thrombosis

✍ Sifontes, Maria T.; Nuss, Rachelle; Hunger, Stephen P.; Waters, Jill; Jacobson, 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 22 KB 👁 2 views

To determine the prevalence of activated protein C resistance and the factor V Leiden mutation (position 1691, arginine 506 to glutamine substitution) in children with thrombosis, plasma samples from children with thrombosis were tested for activated protein C resistance. DNA was analyzed for the fa

Resistance to activated protein C due to

Resistance to activated protein C due to factor V Leiden mutation: high prevalence in patients with post-thrombotic leg ulcers

✍ Y. Gaber; H-J. Siemens; W. Schmeller 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

## Background: Activated protein c (apc) resistance is the most frequently diagnosed heritable thrombophilic defect predisposing to thrombosis. ## Objectives: To determine the prevalence of apc resistance due to factor v leiden mutation in patients with leg ulcers. ## Methods: Within a 2-year-p

Mutation in blood coagulation factor V a

Mutation in blood coagulation factor V associated with resistance to activated protein C

✍ van der Velden, Pieter A.; Reitsma, Pieter H.; Bertina, Rogier M.; Koeleman, Bob 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 513 KB

High prevalence of activated protein C r

High prevalence of activated protein C resistance due to factor V leiden mutation in cases of intrauterine fetal death

✍ H. Rothbart; G. Ohel; J. Younis; N. Lanir; B. Brenner 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 27 KB 👁 1 views

## Objective: To test a possible association between activated protein C resistance and intrauterine fetal death. Methods: The activated protein C anticoagulant activity and factor V R506Q mutation were assessed in 14 nonpregnant women with a history of intrauterine fetal death and 14 healthy cont